URO ONCO

Welcome, this website is intended for all international healthcare professionals in uro-oncology. By clicking the link below you are declaring and confirming that you are a healthcare professional.

You are here

Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy

Duivenvoorden WC, Daneshmand S, Canter D, Lotan Y, Black PC, Abdi H, et al.

J Urol. 2016 Dec;196(6):1627-1633

Editorial comment from Piotr Chlosta: The overall incidence of thromboembolic events (TEEs) in patients undergoing neoadjuvant chemotherapy before radical cystectomy was 14%, with 58% of events occurring preoperatively. Prophylaxis to prevent TEEs may need to be initiated earlier in these patients, during the NAC treatment course.

E-Alert

Subscribe to our E-Alert to keep up to date with the new items in the Resource Centre

Subscribe

URO ONCO is made possible by an unrestricted educational grant from:

The editorial independence of the resource centre is mandatory and recognized by the EAU and Elsevier.

The journal articles, videos and statements published on the resource centre have been selected independently and without influence from Elsevier, European Urology Editors or the sponsor and do not necessarily reflect their opinions or views.